| Autor: |
Perehudoff K; Law Centre for Health and Life, University of Amsterdam, Amsterdam, The Netherlands katrina.perehudoff@gmail.com.; Medicines Law & Policy, Amsterdam, The Netherlands., 't Hoen E; Medicines Law & Policy, Amsterdam, The Netherlands.; Global Health, University Medical Centre Groningen, Groningen, The Netherlands., Mara K; Medicines Law & Policy, Amsterdam, The Netherlands., Balasubramaniam T; Knowledge Ecology International, Geneva, Switzerland., Abbott F; College of Law, Florida State University, Tallahassee, Florida, USA., Baker B; School of Law, Northeastern University, Boston, Massachusetts, USA., Boulet P; Medicines Law and Policy, Contamine sur Arve, France., Kamal-Yanni M; The People's Vaccine Alliance, Oxford, UK., Martin M; Access Campaign, Medecins Sans Frontieres, Geneva, Switzerland., Munoz Tellez V; Intellectual Property and Biodiversity Programme, South Centre, Geneve, Switzerland., Natsis Y; European Social Insurance Platform, Brussels, Belgium., Ortún-Rubio V; Department of Economics and Business, Pompeu Fabra University, Barcelona, Spain., Rathod S; Pharmaceutical Law Professional, Mumbai, India., Torrent M; Menorca School of Public Health, Institut Menorquí d'Estudis, Menorca, Spain., Vawda Y; School of Law, University of KwaZulu-Natal, Durban, South Africa., Villarroel L; Corporación Innovarte, Santiago, Chile., Love J; Knowledge Ecology International, Washington, DC, USA. |
| Abstrakt: |
Competing Interests: Competing interests: FA reports grants from the UNDP and OSF-Public Health Programme. TB and JL report grants from the Foundation to Promote Open Society, Perls Foundation, Unitaid, Gordon R Irlam Charitable Foundation, and Sun Hill Family Foundation. LV reports grants from the Foundation to Promote Open Society, Perls Foundation, and Unitaid. E'tH, KM, PB and VMT report grants from Unitaid. KP reports grants from Unitaid and the Flemish Interuniversity Council-Belgian Department of Development Cooperation. YN reports grants from the European Commission and the Open Society Foundation. MT reports grants from Instituto de Salud Carlos III of the Spanish Ministry of Science and Innovation. SR reports consultancies from Médecins Sans Frontières and Third World Network. MM reports consultancies from Médecins Sans Frontières and The People’s Vaccine Alliance. MK-Y reports consultancies from UNAIDS and Equal International, and payments from the Social Democratic Party of Switzerland. BKB, VO-R and YAV have no grants or contracts to declare. YN participated on behalf of the European Public Health Alliance. PB participated on behalf of Medicines Law & Policy; she is employed by the Drugs for Neglected Diseases initiative. SR participated as an independent professional; he is employed by J. B. Chemicals & Pharmaceuticals Limited. PB and SR did not represent their employers. |
